Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
Possible new PET tracer for early detection of Alzheimer’s
23 April 2021WHO jab experts want more AZ clot data from outside Europe
23 April 2021Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up. In their findings (posted on SSRN/Preprints with The Lancet) they note that they are the first to meet the World Health Organization’s Malaria Vaccine Technology Roadmap goal of a vaccine with at least 75% efficacy.
